Apr 09, 2018 21:17 pm UTC| Business
NEW YORK, April 09, 2018 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on...
Apr 09, 2018 21:00 pm UTC| Business
RED BANK, N.J., April 09, 2018 -- OceanFirst Bank N.A. (OceanFirst), the wholly owned subsidiary of OceanFirst Financial Corp. (NASDAQ:OCFC), announced Jeana M. Piscatelli has joined their team as Senior Vice President...
Apr 09, 2018 20:50 pm UTC| Business
NEW YORK, April 09, 2018 -- PennantPark Floating Rate Capital Ltd. (the "Company") (NASDAQ:PFLT) (TASE:PFLT) announced that it will report results for the second fiscal quarter ended March 31, 2018 on Thursday, May 10,...
UPDATE - Brookstone Big Blue Party™ X Speaker Wins Red Dot Award for High Design Quality
Apr 09, 2018 20:50 pm UTC| Business
MERRIMACK, N.H., April 09, 2018 -- The Red Dot jury has made its decision: After all the products submitted were tested and assessed individually in the course of an evaluation process spanning several days, Big Blue...
PennantPark Investment Corporation Schedules Earnings Release of Second Fiscal Quarter 2018 Results
Apr 09, 2018 20:49 pm UTC| Business
NEW YORK, April 09, 2018 -- PennantPark Investment Corporation (the "Company") (NASDAQ:PNNT) announced that it will report results for the second fiscal quarter ended March 31, 2018 on Wednesday, May 9, 2018 after the...
Kinross Russia operations remain unaffected by U.S. sanctions
Apr 09, 2018 20:46 pm UTC| Business
TORONTO, April 09, 2018 -- Kinross Gold Corporation (TSX:K) (NYSE:KGC) announced today that its mining operations in Russia continue to operate according to plan and remain unaffected by the new sanctions announced by...
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 09, 2018 20:45 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 09, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral...